Study in Letrozole Combined With Metronomic Oral Cyclophosphamide in Elderly Metastasis Breast Cancer Patients

NCT02583828 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Breast Neoplasms
Neoplasm Metastasis

Interventions

DRUG: Cyclophosphamide 50mg
DRUG: Letrozole 2.5 mg

Sponsor

Capital Medical University